SCHEMBL21787408

SCHEMBL21787408

Cc1cc(C(C)(C)O)ccc1-c1ccc(N)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 3/20 0.44
▸ CNR2 P34972 3/20 0.44
▸ ABL1 P00519 1/20 0.41
▸ DHFR P00374 1/20 0.40
▸ KIF11 P52732 1/20 0.38
▸ ESR2 Q92731 2/20 0.38
▸ HSD17B1 P14061 1/20 0.37
▸ ESR1 P03372 1/20 0.36
▸ RORC P51449 2/20 0.36
▸ SLC1A3 P43003 1/20 0.35
▸ SLC1A2 P43004 1/20 0.35
▸ SLC1A1 P43005 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ PRKAB2 O43741 1/20 0.35
▸ PRKAG1 P54619 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6931875 0.89 ABL1 (0.44) CNR1CNR2ABL1ESR2HSD17B1
SCHEMBL8985132 0.85 ESR1 (0.44) CNR1CNR2DHFRKIF11ESR2
SCHEMBL14054473 0.80 KIF11 (0.59) CNR1CNR2DHFRKIF11SLC1A3
SCHEMBL99566 0.78 ALDH1A1 (0.54) DHFRESR2HSD17B1ESR1ALDH1A1
SCHEMBL8953943 0.77 CYP3A4 (0.50) DHFRKIF11ESR2HSD17B1ESR1
SCHEMBL8953996 0.77 ALDH1A1 (0.52) DHFRESR2HSD17B1ESR1ALDH1A1
Methane SCHEMBL28805939 0.77 ALDH1A1 (0.52) DHFRESR2HSD17B1ESR1ALDH1A1
Hydrochloric Acid SCHEMBL7543824 0.77 ALDH1A1 (0.52) DHFRESR2HSD17B1ESR1ALDH1A1
Hydrochloric Acid SCHEMBL10585120 0.77 ALDH1A1 (0.52) DHFRESR2HSD17B1ESR1ALDH1A1
SCHEMBL8146040 0.76 ALDH1A1 (0.56) DHFRESR2HSD17B1ESR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020047487-A1 METHODS FOR TREATING CANCER WITH RORGAMMA INHIBITORS AND STATINS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-03-05 — — WO disclosed
Send feedback